![]() |
Kawasaki Disease |
|
|
Information and facts about Eponymous diseases.Kawasaki disease, also known as mucocutaneous lymph node syndrome, mucocutaneous lymph node disease, infantile polyarteritis and Kawasaki syndrome, is a poorly-understood illness that affects the mucous membranes, lymph nodes, blood vessel walls, and the heart. It was first described in 1967 by Dr. Tomisaku Kawasaki. Incidence, causes, and risk factorsKawasaki disease occurs mainly in Japan, though its incidence in the United States is increasing. Kawasaki disease is predominantly a disease of young children, with 80% of patients younger than 5 years of age, but no other contributing factors are known. The causative agent of Kawasaki disease is still unknown. But current etiological theories center on immunological causes for the disease. Much research is being performed to discover a definitive toxin or antigenic substance, possibly a superantigen, that is the specific cause of the disease. The cardiac involvement and complications are, by far, the most important aspect of the disease. Kawasaki disease can cause vasculitis (inflammation of blood vessels) in the coronary arteries and subsequent coronary artery aneurysms. These aneurysms can lead to myocardial infarction (heart attack) even in young children (rarely). About 20–40% of children with Kawasaki disease will have evidence of vasculitis with cardiac involvement. Kawasaki disease often begins with a high and persistent fever that is not very responsive to normal doses of acetaminophen or ibuprofen. The fever may persist steadily for up to two weeks. The children develop red eyes, red mucous membranes in the mouth, red cracked lips, a "strawberry tongue" and swollen lymph nodes. Skin rashes may occur early in the disease and peeling of the skin in the genital area, hands, and feet (especially around the nails and on the palms and soles) may occur. Symptoms High-grade fever (greater than 39 °C or 102 °F; often as high as 40 °C or 104 °F) that is unresponsive to medication and lasts more than three days (persistent fever lasting at least five days is considered a hallmark sign) Signs and testsA physical examination will demonstrate many of the symptoms listed above. Procedures such as ECG and echocardiography may reveal signs of myocarditis, pericarditis, arthritis, aseptic meningitis, and coronary vasculitis. Tests include: Angiography TreatmentChildren with Kawasaki disease are hospitalized and care is normally shared between pediatric cardiology and infectious disease specialists, although no infectious agent has been demonstrated. It is imperative that treatment be started as soon as the diagnosis is made to prevent damage to the coronary arteries and heart. Intravenous gamma globulin is the standard treatment for Kawasaki disease and is administered in high doses. Marked improvement is usually noted within 24 hours of treatment with IV gamma globulin. Salicylate therapy, particularly aspirin, remains an important part of the treatment but salicylates alone are not as effective as IV gamma globulin. PrognosisWith early diagnosis and treatment, full recovery can be expected. However, about 2% of patients die from complications of coronary vasculitis. Patients who have had Kawasaki disease should have an echocardiogram every 1–2 years to screen for progression of cardiac involvement. ComplicationsComplications involving the heart, including coronary vasculitis and coronary aneurysm, can cause acute myocardial infarction later in life or at a young age. Back to Eponymous diseases index page Can't find what you are looking for? |
Home I Search Site I Site map I Conditions I Symptoms I News Archive I Forum I Contact us I About us I Access Keys All information published on this web site is for information purposes only. The content of this web site should not be used for a conclusive diagnosis or for choosing a treatment. The content on this site has been provided as a guideline and general information it is not intended to replace professional medical care. In all serious cases it is advisable to recieve attention from a qualified medical practitioner. All text is available under the terms of the GNU free documentation license. © Copyright 1998 - 2005 Mens-health-matters.org - All rights reserved Mens-health-matters.org is a trademark |